MARKHAM, ON / ACCESSWIRE / June 1, 2021 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA),today announced that its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has received an update from the United States Environmental Agency registration ("EPA") for its public health claim registrations.
"IFTNA has received new guidance from the EPA agreeing to a request by IFTNA about the public health claims it is seeking. IFTNA has requested that its public health claims be registered in a manner that prevents competitors from leveraging IFTNA's results and registrations in order to shorten their own registration timelines. Under the revised EPA guidance, any competitor will still be required to replicate IFTNA's full test results with respect of the efficacy of PROTX2 for deactivating the various pathogens mandated by the EPA, which in the opinion of the Company is unlikely. This should mean that competitors will be required to move through a full cycle of testing and EPA approvals, which is a multi-year process," stated Giancarlo Beevis, President and CEO of IFTNA.
"All documentation required to facilitate the registration amendment has been fully submitted to the EPA as of the date of this release. Whilst this involves a small amount of additional time being added to the EPA approvals process, it will provide significantly greater protection from IFTNA's intellectual property, which will be of long term benefit to the Company, our customers, and our investors," added Mr. Beevis.
"In the meantime several high-ranking government officials in the United States have intervened on behalf of IFTNA in order to ensure that the EPA expedites final approvals, given the importance those officials see in the prompt and widespread deployment of IFTNA's technologies in the United States," concluded Giancarlo Beevis.